1. Home
  2. Labeler Index
  3. Sagent Pharmaceuticals
  4. 25021-466
  5. NDC Package Code: 25021-466-05 Octreotide Acetate

NDC Package 25021-466-05 Octreotide Acetate

Injection, Solution Intravenous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
25021-466-05
Package Description:
1 VIAL in 1 CARTON / 5 mL in 1 VIAL
Product Code:
25021-466
Proprietary Name:
Octreotide Acetate
Non-Proprietary Name:
Octreotide Acetate
Substance Name:
Octreotide Acetate
Usage Information:
Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (such as carcinoid tumors, vasoactive intestinal peptide tumors) that are found usually in the intestines and pancreas. The symptoms occur when these tumors make too much of certain natural substances (hormones). This medication works by blocking the production of these hormones. By decreasing watery diarrhea, octreotide helps to reduce the loss of body fluids and minerals. Octreotide is also used to treat a certain condition (acromegaly) that occurs when the body makes too much of a certain natural substance called growth hormone. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease. Octreotide works by decreasing the amount of growth hormone to normal levels. This drug is not a cure for these conditions. This medication is usually used with other treatment (such as surgery, radiation, other drugs).
11-Digit NDC Billing Format:
25021046605
NDC to RxNorm Crosswalk:
  • RxCUI: 312068 - octreotide 50 MCG in 1 ML Injection
  • RxCUI: 312068 - 1 ML octreotide 0.05 MG/ML Injection
  • RxCUI: 312068 - octreotide 50 MCG per 1 ML Injection
  • RxCUI: 312069 - octreotide 100 MCG in 1 ML Injection
  • RxCUI: 312069 - 1 ML octreotide 0.1 MG/ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sagent Pharmaceuticals
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • OCTREOTIDE ACETATE 200 ug/mL
    • Pharmacologic Class(es):
  • Somatostatin Analog - [EPC] (Established Pharmacologic Class)
  • Somatostatin Receptor Agonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA091041
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    04-15-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 25021-466-05?

    The NDC Packaged Code 25021-466-05 is assigned to a package of 1 vial in 1 carton / 5 ml in 1 vial of Octreotide Acetate, a human prescription drug labeled by Sagent Pharmaceuticals. The product's dosage form is injection, solution and is administered via intravenous; subcutaneous form.

    Is NDC 25021-466 included in the NDC Directory?

    Yes, Octreotide Acetate with product code 25021-466 is active and included in the NDC Directory. The product was first marketed by Sagent Pharmaceuticals on April 15, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 25021-466-05?

    The 11-digit format is 25021046605. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-225021-466-055-4-225021-0466-05